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Consumption on Vascular FunctionWe thank Dr. Siasos and colleagues for pointing out that habitual
coffee consumption has been associated with improved endothe-
lial function in elderly inhabitants of Ikaria Island (1). The improve-
ment in endothelial function may in part account for the associations
of moderate coffee intake (about 2 to 4 cups daily) with lower risks for
coronary heart disease and stroke (2). Indeed, even in the setting of
endothelium damage, coffee has the ability to prevent arterial
thrombus formation, a beneﬁt that is independent of its caffeine
content (3). Recent studies also indicate that moderate daily coffee
intake may confer protection against nonalcoholic fatty liver disease
(NAFLD), which is present in approximately 30%ofAmerican adults
(4,5). NAFLD is an independent risk factor for coronary athero-
sclerosis (6), and thus coffee’s ability tomobilize fat from the livermay
also contribute to its apparent protective effects against coronary heart
disease. The strong tendency for regular coffee use to promote
dependence, althoughproblematic in some aspects (e.g., headache and
malaise are common caffeine withdrawal symptoms), might also
paradoxically contribute to coffee’s health beneﬁts by reinforcing daily
consumption. Even so, chronic coffee intakemay be best limited to no
more than 4 cups daily to avoid potential adverse effects (7).*James J. DiNicolantonio, PharmD
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1066–74.Diagnosis and Treatment of
Obstructive Sleep Apnea Is Key
to Achieving Optimal Results
After Catheter Ablation of
Atrial FibrillationFein et al. (1) report that obstructive sleep apnea (OSA) adversely
affects the results of ablation for paroxysmal or persistent atrial
ﬁbrillation (AF) except in those who reported using continuous
positive airway pressure. Clearly, the study advances our under-
standing of the role that OSA may play in AF and its management.
The indications for testing for OSA in the study cohort were not
reported, but what is likely, given that patients were predominantly
middle-aged men, is that OSA was underdiagnosed, as the authors
indicated. A key conclusion from this study is that testing patients
with AF for OSA should be undertaken more systematically.
The current deﬁnition of obstructive sleep apnea syndrome re-
quires not only 5 apneas/hypopneas per hour but also daytime
sleepiness. This is despite data showing that <25% of patients with
repetitive obstructive apneas are sleepy (2) and that there is no
relationship between daytime sleepiness and the cardiovascular
consequences of OSA (3) in most studies.
In addition, deﬁnitions of OSA severity based on the average
number of apneas per hour of sleep may be also overly simplistic. In
sleeping humans with obstructive apneas and in pig models of
obstructed breathing, a single apnea can trigger AF. Factors that
lead to the persistence of AF are not entirely understood (4), but
clearly electroanatomic atrial remodeling plays a role in those with a
high burden of AF (5).
We have previously advocated the concept that although OSA
presents with respiratory symptoms, the most important adverse
health effects are cardiovascular (6). In the case of AF, OSA is
such a potent trigger that a case can be made for regarding it as a
symptom of sleep apnea whether or not the patient happens to have
daytime sleepiness. Therefore, if we are to test patients with heart
disease for sleep apnea, we should not restrict our testing to sleepy
patients, as is currently recommended.*Ian Wilcox, PhD
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1810–1.ReplyDiagnosis and Treatment of Obstructive
Sleep Apnea Is Key to Achieving Optimal
Results After Catheter Ablation of
Atrial FibrillationThe association between obstructive sleep apnea (OSA) and car-
diovascular morbidity is well established (1,2). In particular, OSA
has been shown to potentiate atrial ﬁbrillation (AF) substrate in
both animal and human studies (3–7). Our study not only de-
monstrated that OSA adversely affects the results of AF ablation,
but also highlighted the beneﬁcial effect of OSA treatment on
AF ablation outcome in this patient population (8).
Wilcox and colleagues have articulately argued that OSA is
an underdiagnosed disease, likely to coexist in a signiﬁcant pro-
portion of patients with AF. They drew our attention to the current
framework with which we deﬁne OSA and subsequently use to
screen patients. We agree that the current criteria overemphasize
respiratory symptomatology and daytime somnolence, which may
affect a minority of patients with OSA (9–11). The traditional focus
on these symptoms oversimpliﬁes the clinical proﬁle of patients with
sleep apnea and thus underestimates its pronounced cardiovascular
impact, which may be the heralding symptom.
Threshold criteria for OSA testing in patients with AF should
probably be lowered, considering the higher pre-test probability
in this patient population. Until new criteria are formalized, we
should promote awareness of the association between OSA and
AF. Not only is timely identiﬁcation of OSA in AF patients
important in optimizing AF management, but it may mitigate
other deleterious cardiovascular effects.Adam S. Fein, MD
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2008;31:1071–8.Effect of Ivabradine on
Heart Failure With
Preserved Ejection FractionWe read with great interest the paper by Kosmala et al. (1) in which
they report the increased exercise capacity associated with an im-
proved left ventricular (LV) ﬁlling pressure in patients with heart
failure with preserved ejection fraction (HFpEF) treated with
ivabradine. In addition to the mechanisms elegantly discussed by the
authors, we would like to point out other potential important con-
tributors to the observed effect.
Heart rate (HR) is one of the major diastolic function de-
terminants. Indeed, an increase in HR may shorten the diastole
duration, precluding myocardial relaxation from being complete,
and resulting in increased ﬁlling pressures. This may be particularly
